Seelos Therapeutics, Inc. Long-Term Debt, Maturity, Year Two
Seelos Therapeutics, Inc. had Long-Term Debt, Maturity, Year Two of $9.26 million as of 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2023-03-10
- 2022-12-31: Long-Term Debt, Maturity, Year Two $9.26M.
- 2021-12-31: Long-Term Debt, Maturity, Year Two $11.11M.
- 2015-12-31: Long-Term Debt, Maturity, Year Two $3.37M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2022-12-31 | $9.26M 10-K · filed 2023-03-10 |
| 2021-12-31 | $11.11M 10-K · filed 2022-03-04 |
| 2015-12-31 | $3.37M 10-K · filed 2016-03-09 |